| Date | Product | Disease | Phase | Company | Therapeutic area |
|---|---|---|---|---|---|
| 2016-01-21 | NeuVax™ (nelipepimut-S) | HER2 gastric cancer | observational | Galena Biopharma (USA - OR) Dr Reddy's laboratories (India) | Cancer - Oncology |
| 2016-01-21 | Viberzi® (US)/Truberzii® (UE) (eluxadoline) | irritable bowel syndrome with diarrhea (IBS-D) | 3 | Allergan (Ireland) | Digestive diseases - Gastrointestinal diseases - Inflammatory diseases |
| 2016-01-21 | darleukin (L19- IL2) and fibromun (L19-TNF?) | melanoma | 3 | Philogen (Italy) | Cancer - Oncology |
| 2016-01-20 | IMCgp100, durvalumab (MEDI4736) and tremelimumab | melanoma | 1-2 | Immunocore (UK) MedImmune (USA - global biologics arm of AstraZeneca (UK) Inovio Pharmaceuticals (USA - PA) | Cancer - Oncology |
| 2016-01-19 | rapastinel (GLYX-13) | major depressive disorder (MDD) | preclinical | Allergan (Ireland) | Mental diseases - CNS diseases |
| 2016-01-19 | NRL-1 (intranasal diazepam) | epilepsy patients who experience acute repetitive seizures | Neurelis (USA - CA) | Rare diseases - CNS diseases | |
| 2016-01-19 | GLPG2222 | cystic fibrosis | 1 | Galapagos (Belgium) | Rare diseases - Genetic diseases |
| 2016-01-19 | AssureMDx™ for bladder cancer | bladder cancer | MDxHealth (Belgium) | Cancer - Oncology - Diagnostic | |
| 2016-01-16 | ConfirmMDx® for Prostate Cancer test | prostate cancer | MDxHealth (Belgium) | Cancer - Oncology - Diagnostic | |
| 2016-01-14 | FF-21101 | solid tumors | 1 | Fujifilm Corporation (Japan) | Cancer - Oncology |
| 2016-01-14 | TV003 | dengue fever | 3 | Butantan Institute (Brazil) | Infectious diseases |
| 2016-01-14 | MK-7243 (Grazax® in Europe - grass allergy immunotherapy tablet) | grass pollen allergic rhinoconjunctivitis | 3 | ALK Abello (Denmark) | Allergic diseases - Inflammatory diseases - Respiratory diseases |
| 2016-01-13 | Xtandi® (enzalutamide) | metastatic castration-resistant prostate cancer (mCRPC) | 2 | Medivation (USA - CA) Astellas (Japan) | Cancer - Oncology |
| 2016-01-13 | IONIS-HBV-LRx | hepatitis B | 1 | GSK (UK) Ionis Pharmaceuticals (USA - CA) | Infectious diseases |
| 2016-01-12 | exosome nanomedicine platform | preclinical | Reneuron (UK) | ||
| 2016-01-11 | dipraglurant | Parkinson's disease levodopa-induced dyskinesia (PD-LID) | 2a | Addex Therapeutics (Switzerland) | Neurodegenerative diseases - CNS diseases |
| 2016-01-11 | CAR architecture | Cellectis (France) | |||
| 2016-01-11 | DNA ImmunoBody® vaccine SCIB1 | Stage III/IV malignant melanoma | 1-2 | Scancell Holdings (UK) | Cancer - Oncology |
| 2016-01-11 | laquinimod | Huntington's disease | 2 | Teva Pharmaceutical (Israel) Active Biotech (Sweden) | Genetic diseases - Neurodegenerative diseases - Rare diseases |
| 2016-01-11 | Sleeping Beauty transposon-transposase system | Ziopharm Oncology (USA - MA) | Cancer - Oncology |
